Clostridioides difficile infection: a changing treatment paradigm

Clostridioides difficile infection: a changing treatment paradigm

Clostridioides difficile infection (CDI) poses a persistent challenge in healthcare, with substantial morbidity and mortality implications. This comprehensive review explores current CDI management, emphasising guidelines from IDSA, SHEA, and ESCMID. Additionally, this study spotlights recent drug d...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yousif Al Naser, Marriam AlGashami, Layth Aljashaami
Format:	Article
Language:	English
Published:	Termedia Publishing House 2024-03-01
Series:	Gastroenterology Review
Subjects:	clostridioides difficile infection microbiota faecal transplant drug development.
Online Access:	https://www.termedia.pl/Clostridioides-difficile-infection-a-changing-treatment-paradigm,41,52631,1,1.html
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Can Gut Microbiota Analysis Reveal <i>Clostridioides difficile</i> Infection? Evidence from an Italian Cohort at Disease Onset
by: Roberto Rosato, et al.
Published: (2024-12-01)

Gastroenterological Surgery and Management of Clostridioides difficile Infection: A Review
by: Tomonori Takano, et al.
Published: (2025-01-01)

Analysis of risk factors of Clostridioides difficile infection in patients with inflammatory bowel disease
by: Alicja Jakubowska, et al.
Published: (2024-09-01)

Heterogeneity of Clostridioides difficile asymptomatic colonization prevalence: a systematic review and meta-analysis
by: Daniel De-la-Rosa-Martínez, et al.
Published: (2025-01-01)

A Review of Therapies for <i>Clostridioides difficile</i> Infection
by: Faiza Morado, et al.
Published: (2024-12-01)

A quantitative PCR to detect non-toxigenic Clostridioides difficile
by: Khurshida Begum, et al.
Published: (2025-01-01)

Clinical characteristics and risk factors of Clostridioides difficile infection in children with diarrhoea
by: Ning Wang, et al.
Published: (2025-02-01)

Clostridioides difficile infection and recurrence in cancer patients (CIRCA): A multicentre, international study
by: Pedro Puerta-Alcalde, et al.
Published: (2025-04-01)

Cell Wall Protein 2 as a Vaccine Candidate Protects Mice Against <i>Clostridioides difficile</i> Infection
by: Shaohui Wang, et al.
Published: (2024-12-01)

Abundant geographical divergence of Clostridioides difficile infection in China: a prospective multicenter cross-sectional study
by: Lulu Bai, et al.
Published: (2025-02-01)

Inflammatory Markers and Severity in COVID-19 Patients with Clostridioides Difficile Co-Infection: A Retrospective Analysis Including Subgroups with Diabetes, Cancer, and Elderly
by: Teodor Cerbulescu, et al.
Published: (2025-01-01)

The N-terminus of the Clostridioides difficile transferase A component directs toxin activity and potency
by: Robin M. Mullard, et al.
Published: (2025-01-01)

Metronidazole and Vancomycin Have a Synergic Effect, with Plant Extracts as Helpful Tools to Combat <i>Clostridioides difficile</i> Infections
by: Nancy C. Ruiz-Pérez, et al.
Published: (2025-01-01)

Global burden and trends of the Clostridioides difficile infection-associated diseases from 1990 to 2021: an observational trend study
by: Jun Xia, et al.
Published: (2025-12-01)

Predicting positive Clostridioides difficile test results using large-scale longitudinal data of demographics and medication history
by: Anh Pham, et al.
Published: (2025-01-01)

Comparison of the STANDARD M10 C. difficile, Xpert C. difficile, and BD MAX Cdiff assays as confirmatory tests in a two-step algorithm for diagnosing Clostridioides difficile infection
by: Hyunseul Choi, et al.
Published: (2025-01-01)

Costs and Outcomes of Clostridioides difficile Infections in Germany: A Retrospective Health Claims Data Analysis
by: Katharina Schley, et al.
Published: (2024-11-01)

Risk factors for Clostridioides difficile infection among patients diagnosed with inflammatory intestinal and rheumatological diseases in the biologic era
by: Helena Martínez-Lozano, et al.
Published: (2025-02-01)

Guidelines for Clostridium difficile infection in adults
by: Michał Kukla, et al.
Published: (2020-03-01)

Global insights into the genome dynamics of Clostridioides difficile associated with antimicrobial resistance, virulence, and genomic adaptations among clonal lineages
by: Mohammad Sholeh, et al.
Published: (2025-01-01)

Comparison of Illumina and Oxford Nanopore sequencing data quality for Clostridioides difficile genome analysis and their application for epidemiological surveillance
by: Semeh Bejaoui, et al.
Published: (2025-01-01)

Clinical Practice Guidelines of the Scientific Society for the Clinical Study of Human Microbiome, of the Russian Gastroenterological Association and the Russian Society for the Prevention of Noncommunicable Diseases on the Diagnosis and Treatment of <i>Clostridioides difficile</i> (<i>C. difficile</i>)-associated Disease in Adults
by: V. T. Ivashkin, et al.
Published: (2023-09-01)

PPAR-γ agonist mitigates intestinal barrier dysfunction and inflammation induced by Clostridioides difficile SlpA in vitro
by: Maryam Noori, et al.
Published: (2024-12-01)

Modern Approaches to the Diagnosis and treatment of <i>Clostridioides difficile (C. difficile)</i>-associated Disease in Adults (literature Review and Expert Council Resolution)
by: V. T. Ivashkin, et al.
Published: (2023-08-01)

A retrospective clinical study on the influencing factors of Clostridium difficile infection in elderly patients
by: Yang Chen, et al.
Published: (2025-01-01)

Improved Clinical Outcomes with Appropriate Meropenem De-escalation in Patients with Febrile Neutropenia
by: Tyler Luu, et al.
Published: (2024-12-01)

Severe Diverticulitis Associated to <i>Clostridioides difficile</i> Infection in a 91 Year Old Patient (Clinical Case)
by: A. A. Makushina, et al.
Published: (2022-08-01)

Application of emerging technologies for gut microbiome research
by: Wit Thun Kwa, et al.
Published: (2023-01-01)

Synergistic and off-target effects of bacteriocins in a simplified human intestinal microbiome: implications for Clostridioides difficile infection control
by: Natalia S. Ríos Colombo, et al.
Published: (2025-12-01)

Gut Microecological Prescription: A Novel Approach to Regulating Intestinal Micro-Ecological Balance
by: Zhu L, et al.
Published: (2025-02-01)

Clostridium difficile: An Important Opportunistic Pathogen in Healthcare-Associated Infections
by: Soohyoun Ahn, et al.
Published: (2018-01-01)

Clostridium difficile: An Important Opportunistic Pathogen in Healthcare-Associated Infections
by: Soohyoun Ahn, et al.
Published: (2018-01-01)

The potential of genomic epidemiology: capitalizing on its practical use for impact in the healthcare setting
by: Nicole Pacchiarini, et al.
Published: (2025-01-01)

TRPV4 modulates inflammatory responses and apoptosis in enteric glial cells triggered by Clostridioides difficile toxins A and B
by: Dvison de Melo Pacífico, et al.
Published: (2025-01-01)

Prospects of Using Microbiota Correction Methods in the Treatment of Inflammatory Bowel Disease
by: A. I. Akinshina, et al.
Published: (2019-05-01)

Mycophenolate Mofetil and Clostridium difficile-associated Colitis
by: A. I. Dolgushina, et al.
Published: (2021-12-01)

Metagenomics: a new frontier for routine pathology testing of gastrointestinal pathogens
by: Nicola Z. Angel, et al.
Published: (2025-01-01)

Transplantation of intestinal microbiota: therapeutic potential at diseases of digestive organs
by: E. V. Shrayner, et al.
Published: (2014-11-01)

Influence of gut microbiome composition on effect variations of anti-cholesterol treatment among individual mice
by: Hyemin Oh, et al.
Published: (2024-09-01)

<i>Clostridium difficile</i>-associated disease
by: V. T. Ivashkin, et al.
Published: (2015-12-01)